or Try an Advanced Search...

    Cognitive Disorders Stocks List

    Symbol Grade Name % Change
    ITCI A Intra-Cellular Therapies Inc. 2.11
    OMER B Omeros Corporation 0.99
    ANVS C Annovis Bio, Inc. -2.05
    CGTX F Cognition Therapeutics, Inc. -0.25
    ARCT F Arcturus Therapeutics Ltd. 1.52
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Alzheimer's Disease Disorders Medicine Parkinson's Disease Psychiatric Diagnosis Aging Associated Diseases Cognitive Impairment Dementia Early Stage Alzheimer's Disease Learning Disabilities Neurodegeneration Schizophrenia Addiction Adhd Amphetamine Amyloid Arthroscopy Autism Autism Spectrum Disorder

    Related ETFs - A few ETFs which own one or more of the above listed Cognitive Disorders stocks.

    Symbol Grade Name Weight
    PSIL B AdvisorShares Psychedelics ETF 3.89
    IBRN B iShares Neuroscience and Healthcare ETF 3.71
    XPH B SPDR S&P Pharmaceuticals ETF 3.49
    FBT A First Trust Amex Biotech Index Fund 3.41
    ARKG D ARK Genomic Revolution Multi-Sector ETF 3.22
    View all Cognitive Disorders ETFs...
    Compare ETFs
    Compare IBRN to ARKG Compare PSIL to ARKG Compare PSIL to FBT

        Cognitive Disorders Stocks Recent News

        Date Stock Title
        Nov 1 ITCI Intra-Cellular Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        Oct 31 CGTX Cognition Therapeutics Presents Poster of Participant Demographics from Phase 2 Dementia with Lewy Bodies Study at CTAD
        Oct 31 ARCT Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 7, 2024
        Oct 31 ANVS IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Maria Maccecchini, CEO of Annovis Bio
        Oct 31 ITCI Intra-Cellular Therapies Inc (ITCI) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ...
        Oct 30 ITCI Intra-Cellular Therapies, Inc. (ITCI) Q3 2024 Earnings Call Transcript
        Oct 30 ARCT Arcturus Therapeutics (ARCT) Upgraded to Buy: What Does It Mean for the Stock?
        Oct 30 ITCI Intra-Cellular jumps on Q3 beat as Caplyta outlook brightens
        Oct 30 ITCI ITCI Q3 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales
        Oct 30 ITCI Intra-Cellular Therapies (ITCI) Reports Q3 Loss, Tops Revenue Estimates
        Oct 30 ITCI Intra-Cellular: Q3 Earnings Snapshot
        Oct 30 ITCI Intra-Cellular Therapies GAAP EPS of -$0.25 misses by $0.04, revenue of $175.4M beats by $3.05M
        Oct 30 ITCI Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance
        Oct 29 ITCI Intra-Cellular Therapies Q3 2024 Earnings Preview
        Oct 29 CGTX Cognition Therapeutics Announces Results of Pre-specified Analysis of SHINE Study Data Presented at CTAD
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Alzheimer's Disease Disorders Medicine Parkinson's Disease Psychiatric Diagnosis Aging Associated Diseases Cognitive Impairment Dementia Early Stage Alzheimer's Disease Learning Disabilities Neurodegeneration Schizophrenia Addiction Adhd Amphetamine Amyloid Arthroscopy Autism Autism Spectrum Disorder
        Cognitive Disorders

        Cognitive Disorders are a group of mental health conditions that affect a person's ability to think, remember, and learn. These disorders can range from mild to severe and can include conditions such as dementia, Alzheimer's disease, and traumatic brain injury. Symptoms of cognitive disorders can include difficulty with memory, concentration, problem-solving, and decision-making. Treatment for cognitive disorders typically involves a combination of medication, therapy, and lifestyle changes.

        Browse All Tags